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ABSTRACT 
The objective of the study is to investigate the hydro alcoholic leaves extract of Leucomeris spectabilis (Asteraceae) for 
hypoglycemic effects in normal and diabetic rats. Acute oral toxicity study indicated that HAE was safe up to a dose of 
2000 mg/kg body weight of rats and screened for antidiabetic activity in alloxan (120 mg/ kg, i.p.) induced diabetic rats 
for 21 days along with phytochemical analyses of HAE were also carried out. In-vivo evaluation of the extracts 
decreased blood sugar levels with significant improvement in blood glucose level, serum marker enzymes (SGPT, 
SGOT and ALP) and the content at the end of 1, 2 and 3rd weeks after HAELC treatment. The results suggest of 
antidiabetic activity study revealed that HAE possesses significant (p < 0.05) hypoglycemic activity compared to 
diabetic rats group. The results showed that the hydroalcoholic leaves extract has significantly most of effect in 
200mg/kg. 
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1. INTRODUCTION 
Traditionally, herbs used for the treatment of many 
disease and disorders in which herbal medicines are the 
synthesis of therapeutic usefully for stage of life of 
practicing physicians of indigenous system of medicine 
for over hundreds of years while nutraceuticals are 
nutritionally or medicinally enhanced foods with health 
benefits of recent origin and marketed in developed 
countries
1
. The marketing of the former under the 
category of the latter is unethical. Herbal medicines are 
also in great demand in the developed world for primary 
health care because of their efficacy, safety and lesser 
side effects 
2
. In this era of rapid industrial development, 
ever increasing population growth rate throughout the 
world.   
Diabetes mellitus (DM) is the most common endocrine 
disease worldwide and is a prevalent serious chronic 
metabolic disease which result due to no production of 
insulin causing type 1 DM or due to partial and/or 
insufficient production of insulin causing type 2 DM. 
Furthermore, insulin resistance cause hyperglycemia 
and diabetes due to the inability of the cells to use 
insulin properly and efficiently. Some to the serious 
complication of diabetes include nephropathy, 
retinopathy, and neuropathy, foot ulcers among other 
symptoms 
3, 4, 5
. As per the reports published by WHO in 
2016; about 173 million people suffer from diabetes 
mellitus. The number of people with diabetes mellitus in 
Indonesia is ranked the fourth largest number of people 
with DM, after India, China, and the United States, 
which is about 8.4 million people. The global 
prevalence of diabetes has increased from 4.7 to 8.5% 
i.e. 108 million in 1980 to 422 million in 2014. Diabetes 
mellitus (DM) is characterized by chronic 
hyperglycemia and alterations in carbohydrate, lipid and 
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protein metabolism, associated with absolute or relative 
deficiencies in insulin secretion and/or insulin action 
6, 7
. 
It consists of several types, one of which is noninsulin 
dependent diabetes mellitus (type 2 DM). This type of 
DM is more common, reaching 90–95% of the 
population with DM and is a long-lasting malady of 
energy metabolism involving impaired glucose 
breakdown as well as reduced insulin action 
8, 9
. This 
increasing trend in type 2 DM has become a serious 
medical concern worldwide that prompts every effort in 
exploring for new therapeutic agents its progress 
10
. 
Natural resources provide a huge and highly diversified 
chemical bank from which we can explore for potential 
therapeutic agents by bioactivity-targeted screening. The 
high prevalence of diabetes as well as its long-term 
complications has led to an ongoing search for 
hypoglycemic agents 
11,12
. 
The treatment of hyperglycemia in diabetic patients is 
oral hypoglycemic agents. The last two decades have 
witnessed the introduction of many classes of these 
agents, and their optimal use and side effects are 
gradually recognized. Seven approved major classes of 
oral anti-hyperglycemic agents are currently available: 
MET, SU, glinides (GLN), thiazolidinediones (TZD), 
alpha-glucosidase inhibitors (AGI), dipeptidyl 
peptidase-4 inhibitors (DPP-4I), and the most recent 
sodium glucose cotransporter-2 inhibitors (SGLT-2I)
13
. 
Although a number of pharmacological approaches to 
the treatment of NIDDM are currently available, it is 
clear that none is ideal for the treatment of a great 
majority of NIDDM patients. Thus development of 
newer therapeutic approach remains highly desirable 
14
.  
In view of the side effects associated with the treatment 
by insulin and synthetic drugs which are available at 
present, searching for effective and safer hypoglycemic 
plant drugs is going on all over the world. Herbal 
medicines play a vital role in this part to prevent side 
effects 
15
.  
Therefore, researchers try to explore the potential 
antidiabetic agents with the mechanism of action of α-
glucosidase inhibition in several plant species from four 
families: Apocynaceae, Clusiaceae, Euphorbiaceae, and 
Rubiaceae. The four families were chosen because 
members of some species have been scientifically 
proven to have antidiabetic activity. Today explore 
much other family show antidiabetic activity 
16
. The 
literature survey on journal, library and other of 
Leucomeris spectabilis plant uses, activity or full details 
has not found. 
2. MATERIALS AND METHODS  
2.1. Plant material 
The leaves of Leucomeris spectabilis were collected 
from Bareilly, near Uttrakhand border hills, Uttar 
Pradesh, India. It was authenticated by Dr. Ashok 
Kumar, Department of Botany, IFTM University, 
Moradabad, Uttar Pradesh, India. 
2.2. Preparation of extracts 
Leucomeris spectabilis leaves were made free from the 
adherent foreign material and air-dried, coarsely 
powdered and packed into soxhlet apparatus and 
extracted using hydro alcoholic solvent. The extraction 
was carried out for about 40hr. The extract obtained was 
dried at 45°C in hot air oven till green colored semisolid 
mass was obtained. The yield obtained was 18.5% and 
the semisolid extract was stored in a refrigerator at 4°C 
until further use 
17
. 
2.3. Phytochemical screening 
Preliminary phytochemical screening of the HAE was 
carried out for detection of the presence of various 
phyto-constitutents like alkaloids, glycosides, 
flavonoids, phenolic compounds, tannins, saponins, 
proteins, amino acids and steroids 
18
. 
2.4. Animals  
Albino rats of either sex weighing between 150-200gm 
were used for this investigation. Housed individually in 
polypropylene cages, maintained under standard 
conditions (12 h light and 12 h dark cycle, 25±30
◦
C, 35–
60% relative humidity), and the protocols related with 
animal experiment were approved by Institutional 
Animal ethics committee (IAEC). All the chemicals 
were of AR grade and procured from CDH (P) Ltd, New 
Delhi. 
2.5. Acute Toxicity Tests 
Acute toxicity studies were conducted by using albino 
rats of either sex. Over-night fasted rats were randomly 
divided into five groups of six animals each. Rats of 
different groups were administered 2000 mg/kg b.w. of 
the HAE. One group was maintained as Normal control 
and was given vehicle alone. The animals were observed 
individually symptoms of toxicity and mortality if any, 
and then periodically for the next 24 h, and then at every 
24 h for any signs of acute toxicity over a period of 14 
days. The acute toxicity study was done as per OECD 
guideline-425. Acute oral toxicity studies revealed the 
nontoxic nature of aqueous extract of Leucomeris 
spectabilis. There was no morbidity observed or any 
profound toxic reactions found a dose of 2000 mg/Kg 
p.o. which indirectly pronouns the safety profile of the 
plant extract. The doses 100 and 200 mg/kg b.w were 
selected for the evaluation of anti-diabetic activity. 
2.6. Anti-diabetic activity in Alloxan-induced diabetic 
rats. 
Diabetes was induced in overnight fasted animals by a 
single intra peritoneal (i.p) injection of Alloxan 
monohydrate120 mg/ kg b.w. was dissolved in normal 
saline. The solution should be fresh and prepared just 
prior to the administration. The animals confirmed as 
diabetic (after 72 h of Alloxan injection) by the elevated 
plasma glucose levels (200– 300 mg/dl) was used for the 
experiment. 
The animals were divided randomly into five groups of 
six rats in each group.  
Group I rats served as Normal control were given 
vehicle (3% tween 80 v/v in normal saline 10 ml/kg 
b.w) alone.  
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Group II rats served as Positive control (120 mg/kg b.w 
Alloxan diabetic control) and were administered with 
vehicle alone.  
Group III rats were received the standard drug, 
metformin hydrochloride (100 mg/kg b.w.).  
Group IV and V rats were treated with HAE at 100 
mg/kg b.w. and 200 mg/kg b.w., respectively.  
Treatments doses were given orally using a cannula 
once daily for a period of 21 days. Blood was collected 
from the tail vein each time for the determination of 
glucose levels on 0, 7, 14 and 21 day. Blood glucose 
levels were measured by the GOD-POD method 
19,20
. 
2.7. Statistical analysis 
Values are represented as mean± SEM of three replicate 
studies. Statistical analysis was performed using the 
Graphpad 5.0 statistical software package, for Windows. 
Statistical differences at 5% level of probability (p < 
0.05) between the groups were analyzed by one-way 
ANOVA followed by Dunnett’s test. 
3. RESULTS 
3.1. Phytochemical screening 
The results of preliminary phytochemical screening 
revealed the presence of phyto-constitutents in plant 
leaves (Table 1). 
3.2. Acute toxicity study  
No sign and symptoms of acute toxicity and mortality 
up to 2000 mg/kg body weight dose were observed 
during the whole experimental period. The body weight 
and food consumption were normal compared to vehicle 
treated rats. For further studies, the doses were fixed as 
100 and 200 mg/kg body weight. 
Table 1: Preliminary phytochemical tests to identify the 
presence of various phytochemicals in Hydro-alcoholic 
extract of Leucomeris spectabilis leaves. 
S.N. Phytochemical Parameters HAELS 
1. Alkaloids + 
2. Carbohydrates + 
3. Glycosides + 
4. Proteins - 
5. Tannins & Phenolic 
compounds 
+ 
6. Flavonoids + 
7. Steroids - 
8. Amino Acids + 
9. Fats And Oils - 
(+): Presence, (-): Absence  
 
3.3. Effect of HAE on blood glucose levels in diabetic 
rats 
Alloxan treated diabetic rats were increase the levels of 
blood glucose in comparison to normal rat values. The 
diabetic rats treated with metformin (100 mg/kg) also 
showed significantly considerable lowering effect in 
blood glucose level when compared to diabetic treated 
rats. 
In diabetic rats, the blood glucose level (Fig. 1) were 
significantly decreased. After 7, 14, 21 days of treatment 
with HAE at 100 and 200 mg/kg. The activity of HAE 
was found lesser than that of metformin (100 mg/kg) 
treated group. Results of the effect of metformin and 
HAE on blood glucose levels in normal and diabetic rats 
are depicted in Table 2. 
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Figure 1: Effects of HAELC on blood glucose level at 0, 7, 14, 21 days. 
Table 2: Effect of repeated dose treatment of Leucomeris spectabilis leaves on blood glucose level in alloxan-induced 
diabetic rats 
Group Dose Blood glucose level (mg/dl) (Mean ± SEM) 
0 day 7 day 14 day 21 day 
I Normal Control (Tween 80 3%) 10 ml/kg 116.16±1.24** 119.83±0.792** 123.00±0.632** 121.5±0.670** 
II Positive Control (Alloxan) 120 mg/Kg 217.50±0.763 227.16±1.07 226.83±1.24 220.8333±2.24 
III Standard (Metformin) 100 mg/Kg 206.33±1.40* 126.33±0.843* 122.00±0.632* 106.5±1.33* 
IV Hydro-alcoholic Extract (Low Dose) 100 mg/Kg 211.50±2.32* 134.83±0.600* 125.50±0.428* 122.5±0.763* 
V Hydro-alcoholic Extract (High Dose) 200 mg/Kg 212.33±2.33* 123.16±1.22* 121.16±2.79* 116.5±2.57* 
All values are expressed in mean ± SEM. Statistical analysis of data was carried out by one way ANOVA followed by Dunnett’s 
test. *(p<0.05) when compared with the Positive Control (Diabetic control) group. 
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3.4. Effect of HAE on SGOT, SGPT, ALK-Phosphate, total serum bilirubin, bilirubin direct, bilirubin indirect, 
serum total protein, serum albumin and globulin in diabetic rats:. 
The results indicated from (Fig. 2 and 3). 
Table 3: Effect of HAE of Leucomeris spectabilis leaves on SGOT, SGPT, and ALK-Phosphate in normal and 
diabetic rats 
Groups Dose SGOT SGPT ALK-Phosphate 
I Normal Control 
(Tween 80 3%) 
10 ml/kg 211.35±1.42* 131.04±1.22* 402.6±0.807*** 
II Positive Control 
(Alloxan) 
120 mg/Kg 450.2±2.06 352.77±1.06 754±0.899 
III Standard (Metformin) 100 mg/Kg 173.04±0.747* 134.04±0.611* 375.35±1*** 
IV Hydro-alcoholic Extract (Low 
Dose) 
100 mg/Kg 254.99±1.48* 176.38±1.11* 491±1.48*** 
V Hydro-alcoholic Extract (High 
Dose) 
200 mg/Kg 205.92±0.768* 155.82±1.17* 414.85±0.949**
* 
 
All values are expressed in mean ± SEM. Statistical analysis of data was carried out by one way ANOVA followed by 
Dunnett’s test. *(p<0.05) when compared with the Positive Control (Diabetic control) group. 
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Figure 2: Effects of HAELC on biochemical parameter as Total Serum Bilirubin, Bilirubin direct and Bilirubin 
indirect. 
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Figure 3: Effects of HAELC on biochemical parameter as SGOT and SGPT. 
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Figure 4: Effects of HAELC on biochemical parameter as ALK-Phosphate. 
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It is increase in activities of SGOT, SGPT and ALK-
Phosphate in diabetic rats, The diabetic rats treated with 
Metformin 100 mg/kg, p.o., and HAE (100 & 200 
mg/kg)given considerable lowering effect on the levels 
of serum marker enzymes SGOT, SGPT and ALK-
Phosphate were compared to diabetic control rats (Table 
3). The biochemical parameter results indicated (Fig. 4), 
there was increase in activities of total bilirubin, 
bilirubin direct and bilirubin indirect level in diabetic 
rats. The diabetic rats treated with Metformin 100 
mg/kg, p.o., and HAE 200 mg/kg given considerable 
decreasing effect on the level of total serum bilirubin, 
bilirubin direct and bilirubin indirect, but the dose or 
HAE 100 mg/kg given no significant effect on level of 
this parameter were compared to diabetic control rats. In 
which increase in activity of serum total protein, serum 
albumin and globulin level in diabetic rats. The diabetic 
rats treated with Metformin 100 mg/kg, p.o., and HAE 
200 mg/kg given significant effect on the level of serum 
total protein, serum albumin and globulin were 
compared to diabetic rats. In which the dose of HAE 
100 mg/kg given no significant effect on level of serum 
total protein, serum albumin and globulin (Fig. 5, 6 and 
7) were compared to diabetic rats (Table 4) 
 
Table 4: Effect of HAE of Leucomeris spectabilis leaves on Serium Bilirubin, Bilirubin Direct, Bilirubin Indirect, 
Total Protein, Serium Albumin and Serium Globulin in normal and diabetic rats. 
Groups Dose Serium 
Bilirubin 
Bilirubin 
Direct 
Bilirubin 
Indirect 
Total Protein Serium 
Albumin 
Globulin 
I Normal 
Control 
(Tween 80 3%) 
10 
ml/kg 
0.81±0.012* 0.245±0.012* 0.613±0.013* 5.8±0.096609ns 3.2±0.089*** 2.6±0.096*** 
II Positive 
Control 
(Alloxan) 
120 
mg/Kg 
2.05±0.076 1.45±0.076 1.72±0.094 6.1±0.139044 3.9±0.106 3.4±0.141 
III Standard 
 (Metformin) 
100 
mg/Kg 
0.922±0.011* 0.34±0.011* 0.728±0.011* 5.2±0.121106*** 3.0±0.077*** 2.3±0.106*** 
IV 
Hydroalcoholic 
Extract (Low 
Dose) 
100 
mg/Kg 
1.75±0.076ns 0.76±0.015ns 0.95±0.012ns 
 
5.8±0.106ns 3.7±0.139ns 
 
3.0±0.152ns 
V 
Hydroalcoholic 
Extract  (High 
Dose) 
200 
mg/Kg 
1.29±0.074* 0.46±0.009* 
 
0.75±0.051* 5.5±0.096609** 
 
3.4±0.096** 2.6±0.106*** 
All values are expressed in mean ± SEM. Statistical analysis of data was carried out by one way ANOVA followed by Dunnett’s 
test. *(p<0.05) when compared with the Positive Control (Diabetic control) group. 
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Figure 5: Effects of HAELC on biochemical parameter as Serum total protein. 
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Figure 6: Effect of HAELC on biochemical parameter as Serum Albumin. 
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Figure 7: Effects of HAELC on biochemical parameter as Globulin. 
4. DISCUSSION 
Hydro-alcoholic extract (HAE) of Leucomeris 
spectabilis leaves did not demonstration toxicities in the 
dose of (2000 mg/kg b.w.) experimentally on animals 
which indicated the safety of bioactive phytochemical 
present in the extract. The intra-peritoneal 
administration of Alloxan leading to decreased in release 
of insulin which ultimately results show induces of 
diabetes mellitus in rats. The treated group of metformin 
and HAE demonstrated significant decrease the level of 
blood glucose when compared with diabetic rat son 0, 7, 
14 and 21 days of treatment. The serum marker enzymes 
SGOT, SGPT and AKL-Phosphate are important 
markers of liver function. The rise in the activities of 
SGOT, SGPT and ALK-Phosphate in plasma of diabetic 
rats due to the outflow of these enzymes from the liver 
cytosol into the blood stream which was an sign of the 
hepatotoxic effect in liver. The serum biochemical 
parameters total bilirubin, bilirubin direct, bilirubin 
indirect, serum total protein, serum albumin and globulin 
increases show the deficiency of this content in plasma 
which was sign of toxicity causable effect in the body of 
parameter. The biochemical parameter increase in 
activities of total bilirubin, bilirubin direct, bilirubin 
indirect, serum total protein, serum albumin and globulin 
level in diabetic rats. The diabetic rats treated with 
Metformin 100 mg/kg, p.o., and HAE 200 mg/kg given 
considerable decreasing effect on the level of total serum 
bilirubin, bilirubin direct, bilirubin indirect, serum total 
protein, serum albumin and globulin but the dose or 
HAE 100 mg/kg given no significant effect on level of 
this parameter were compared to diabetic control rats 
4,19,20,21
. 
5. CONCLUSIONS 
The present study concludes that HAE of Leucomeris 
spectabilis showed potent hypoglycemic activity in 
diabetic rats compared to positive control (alloxan) 
induced rats and exhibited antidiabetic effect potentially 
on 0, 7, 14 and 21 days of treatment with significant 
improvement in blood glucose level. The serum marker 
enzymes SGOT, SGPT, ALK-Phosphate and the content 
total serum bilirubin, bilirubin direct, bilirubin indirect, 
serum total protein, serum albumin and globulin show 
reducing effect when compared to diabetic rats group. 
This effect may be due to the presence of glycosides, 
flavonoids, alkaloids and other constituents present in 
the leaves which could act synergically or independently 
in enhancing the activity of glycolytic and 
gluconeogenic enzymes. The result suggests that it is 
worth undertaking further studies on possible usefulness 
of the Leucomeris spectabilis leaves in diabetes mellitus. 
The phytochemical analyses need be executed in order 
to identify the possible flavonoid components having 
antidiabetic activity. 
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